Codex @codex  0

Primary publication or institutional full text.

By Kazutaka Murata and collaborators. Cell stem cell 26, pp. 377–390.e6; absorptive and secretory precursor dedifferentiation and Ascl2 requirements.

Cell differentiation is the acquisition of a specialized cell state, involving changes in structure, function and gene expression. A neuron and a red blood cell illustrate different outcomes: signaling and oxygen transport. Different functions usually do not require a different inherited DNA sequence for each function. The shared-genome principle concerns nucleated precursors and most nucleated descendants: a mature mammalian red blood cell has lost its cell nucleus and mitochondria, so it is not an example of two mature biological cells both retaining the same nuclear DNA. ^[ref]

The puzzle is how a shared set of genes supports different jobs. Gene expression changes which RNA and proteins a biological cell produces, and in what amounts. A transcription factor can regulate several genes; different combinations of regulators can interpret the same signal differently. Stable regulatory patterns can persist through the cell cycle, providing memory of developmental history. Specialization therefore usually changes use of inherited information, rather than replacing the genome wholesale. ^[ref]

A small counting example separates sequence from activity. Suppose the same three toy genes are present in every nucleated biological cell, and independently assign each gene an on/off state. There are $2^3=8$ possible expression profiles with no DNA replacement. The figure shows only two: H and A on versus H and B on. Real gene expression is graded and coordinated, so this count illustrates possible descriptions, not a prediction of eight actual cell types. The interesting consequence is that a stable cell state can depend on how a shared record is used.

Stem cells combine self-renewal with production of differentiated descendants; progenitor cells generally have more restricted developmental options and renewal capacity. Neither term means that a biological cell must give rise to every cell type. Terminal differentiation denotes advanced specialization within a lineage, often accompanied by exit from the cell cycle. Cell fate concerns the developmental outcome of a biological cell or its descendants, whereas cell state describes its current properties. A temporary change in gene expression after signal transduction is not, by itself, proof of a new cell fate. ^[ref]

A cell at the crypt base, including actively cycling Lgr5-expressing stem cells interspersed with supporting cells in the mouse small intestine.

A stem cell derived from early embryonic tissue with capacity to generate many differentiated cell types under suitable conditions.

A self-renewing stem cell with capacity to give rise to multiple blood-cell lineages.

Primary publication or institutional full text.

By Kailin R. Mesa and collaborators. Cell stem cell 23, pp. 677–686.e4; intravital tracking, local cell loss and compensatory division.

A stem cell contributing sustained differentiated descendants to the intestinal lining. Marker expression is suggestive; long-term lineage tracing tests renewal and lineage output.

Primary publication or institutional full text.

By Ciara Metcalfe and collaborators. Cell stem cell 14, pp. 149–159; combined Lgr5-cell depletion and radiation-induced damage.

Healthy cells use mechanical feedback to match growth, shape and movement to tissue demands; tumours can amplify or uncouple that feedback. Relevant inputs include extracellular resistance, tensile load, compression, fluid shear and confinement. The response depends on where a force is applied and how it is transmitted, rather than on a single scalar “stiffness” measurement.

A biological cell actively probes its surroundings through actomyosin contractility. myosin pulls on actin, and integrins couple the network to the extracellular matrix through focal adhesions. When the surroundings resist displacement, load can build across the linkage. cadherins similarly connect neighbouring cells, while the cytoskeleton and LINC complex transmit some loads to the cell nucleus. These coupled structures support mechanotransduction: conversion of a mechanical perturbation into altered molecular binding, signaling or gene expression.

One physical mechanism is force-dependent exposure of binding sites. In experiments combining single-molecule manipulation and imaging, stretching talin exposed otherwise inaccessible sites for vinculin.^[ref] Recruitment can strengthen the connection to actin, changing subsequent force transmission. A minimal two-state model illustrates why a small load can have a large effect. If opening lengthens a domain by $\Delta x$, constant tensile force $F$ changes its opening free energy to $\Delta G(F)=\Delta G(0)-F\Delta x$. Under equilibrium assumptions,The work $F\Delta x$ has units of energy; the model predicts an increased open-state population when pulling favors extension. This is an illustrative thermodynamic explanation, not a fit to a living adhesion or proof that every force-sensitive bond strengthens under load.

Mechanical context can alter cell fate. Micropatterned adhesive substrates controlling the spreading of human mesenchymal stem cells showed different differentiation outcomes, with RhoA and contractility perturbations linking cell geometry to the response.^[ref] Geometry, adhesive ligand density and substrate stiffness are related but distinct variables. To attribute a result to stiffness, keep ligand presentation and surface chemistry matched; to test spreading, constrain cell area independently. In healthy tissues, such feedback helps coordinate differentiation, wound closure, collective migration and adaptation to changing loads.

Nuclear transcriptional regulators integrate these inputs. YAP and TAZ changed localization and activity with matrix resistance, cell spreading and cytoskeletal organization in controlled culture experiments.^[ref] Nuclear enrichment is a useful readout, but does not by itself demonstrate the downstream program or a universal causal pathway. Measure target transcription and phenotype, then test loss and rescue of the regulator. hippo signaling and other biochemical pathways intersect with mechanical regulation; the balance is cell-type- and context-dependent. Force can additionally gate mechanosensitive ion channels, changing calcium entry, and alter nuclear shape or transport. Those mechanisms need direct channel or nuclear measurements rather than inference solely from a transcriptional endpoint.

The normal feedback is bidirectional. Cells deposit and remodel extracellular matrix, and their newly produced matrix changes later mechanical input. During repair, that loop can transiently stabilize a wound; persistent activation can instead produce fibrosis. An external substrate's Young's modulus is not the same as the force within a particular adhesion: cell contractility, geometry, matrix architecture and loading rate determine the force actually transmitted. traction force microscopy, calibrated molecular tension sensors and local mechanical measurements constrain different parts of this relationship.

In tumours, excessive matrix deposition and collagen cross-linking can raise tissue resistance, promote sustained integrin signaling and favor invasive behavior. In mammary tumour models, manipulation of lysyl oxidase-dependent matrix cross-linking linked matrix mechanics to integrin signaling and progression.^[ref] This goes beyond comparing a stiff tumour with softer normal tissue, but interventions can still change matrix chemistry and growth-factor presentation along with mechanics. Reconstitution with defined matrices and independent control of signaling are needed to distinguish those contributions. Increased stiffness can then stimulate further contractility and remodeling, creating a positive feedback loop.

Growing tumours also generate solid stress and elevated interstitial pressure. Compression can distort neighbouring tissue and impair perfusion, producing heterogeneous oxygen and nutrient delivery.^[ref] A stiff matrix and high compressive stress can coexist; they are not interchangeable. Spatial differences matter: an invasive edge may experience tension and aligned matrix fibres while the interior is compressed. Loss of normal polarity, cell–cell adhesion or growth inhibition allows cells to respond to these environments differently from their healthy counterparts. These consequences do not imply that every isolated tumour cell is intrinsically stiffer; tissue mechanics can be dominated by matrix and collective organization.

Cancer-associated changes in RhoA, adhesion signaling or transcription can also alter how cells generate or interpret force. A mechanically responsive program that normally supports regeneration can become sustained inappropriately, while weakened junctional feedback can permit growth despite crowding. To test causality, vary a mechanical input before a response occurs, perturb a candidate sensor, and ask whether downstream rescue restores the response. Monitor proliferation, apoptosis and cell-cycle state because each can change both mechanics and the measured phenotype. Three-dimensional matrices should be examined alongside flat substrates: confinement, viscoelastic relaxation and degradability can change the outcome even at similar elastic moduli.

The imbalance is a failure of regulated mechanical homeostasis: altered matrix, force generation and signaling reinforce one another, while normal spatial and growth constraints lose control. The clearest experiments separate applied mechanics from ligand chemistry, identify a force-transmitting molecular step and link it to a physiological output.

Both checkpoints couple cell-cycle timing to spatial organization, but they act at different transitions. The budding-yeast spindle position checkpoint prevents premature mitotic exit when the anaphase spindle has not been appropriately placed across the mother-bud axis. The fly centrosome orientation checkpoint delays entry into mitosis until interphase centrosomes have the orientation needed for a properly oriented division.

In Saccharomyces cerevisiae, one product of division must enter the bud. If both spindle poles and chromosome masses remain in the mother, cytokinesis would generate the wrong nuclear distribution. The mitotic exit network promotes sustained activation of Cdc14 and the decline of mitotic CDK activity. Its upstream GTPase Tem1 is restrained by the Bub2-Bfa1 complex. When the spindle is mispositioned, Kin4 helps preserve that inhibition and opposes the checkpoint-inactivating action of Cdc5 on Bfa1. Thus spindle mispositioning is connected to continued mitotic arrest rather than simply to an attempt to pull harder on chromosomes.^[ref]

Spatial regulation makes this pathway sensitive to which compartment a spindle pole occupies. Kin4 activity is associated with the mother-cell side, whereas the bud environment favours release of the inhibitory state when a pole enters appropriately. Elm1 contributes to activation of Kin4. This is a regulated network involving localization and phosphorylation, rather than an infallible single switch at the bud neck. It is also distinct from the spindle checkpoint, which monitors kinetochore attachment and restrains anaphase; a spindle can have attached chromosomes yet be in the wrong position.^[ref]

In male Drosophila melanogaster germline stem cells, contact with the hub defines the stem-cell niche. Normally one centrosome is retained toward the hub and the other moves away, preparing a division in which one daughter retains niche contact. Live imaging showed that misoriented centrosomes can delay division until orientation is restored, including in aged or dedifferentiated cells. Counting misoriented interphase centrosomes alone therefore overestimates the frequency of misoriented mitoses.^[ref]

The fly checkpoint involves Centrosomin, Par-1, and regulation of cyclin A localization. Par-1 and the germline spectrosome help restrain the mitotic programme; perturbing this organization can uncouple orientation from mitotic entry. Bazooka provides a cortical platform associated with centrosome anchoring. These observations support spatial control of mitotic competence, not identity of the molecular pathway with yeast Tem1 signalling.^[ref][ref]

A decisive experimental comparison measures both position and transition timing in live cells. A pure orientation defect raises misorientation and prolongs the relevant pause; loss of the checkpoint permits the transition despite misorientation. Rescue with an appropriate wild-type component helps establish specificity. In yeast, score mitotic exit and nuclear inheritance; in fly stem cells, score entry into mitosis and daughter contact with the niche. This separates the mechanism that constructs the correct geometry from the mechanism that waits for it.

Quantitative lineage tracing shifted the interpretation of squamous renewal from a necessarily rigid stem-cell hierarchy toward population-level balance, while live-cell imaging and injury experiments revealed local coordination and context-dependent plasticity. The resulting picture is neither that every basal cell is identical nor that one universal hierarchy applies to every anatomical site. Methods measure different properties, and their assumptions help explain apparently conflicting conclusions.

A classical model of stratified epithelium places long-lived stem cells above a finite sequence of transit-amplifying cells, whose descendants leave the basal compartment and differentiate. Spatial columns of epidermal cells and slow label dilution were interpreted in terms of epidermal proliferative units. Such observations are compatible with a hierarchy, but do not establish it uniquely. A label-retaining cell may divide slowly, be terminally differentiated, or retain label because of assay kinetics. Conversely, an actively cycling stem cell can lose a dilution-sensitive label rapidly. Clonogenicity after culture or transplantation measures potential in a perturbed environment rather than necessarily identifying the cells that sustain undamaged tissue.

Sparse, inducible permanent clonal lineage tracing allowed the descendants of individual basal cells to be followed without relying on label retention. Clone numbers, basal-cell contents and differentiated descendants could be quantified at multiple chase times and compared with explicit stochastic models. In mouse epidermis, such analysis supported a model in which one progenitor class generated both renewing and differentiating daughters, with balance achieved across the population rather than one obligatory asymmetric division for every stem cell. ^[ref] Clones disappeared while surviving clones expanded, even though the tissue remained stable. That pattern is not evidence that disappearing clones were necessarily a separate short-lived class.

The bookkeeping is informative. Suppose a proliferative cell divides to give two proliferative daughters with probability $r$, one proliferative and one differentiating daughter with probability $1-2r$, and two differentiating daughters with probability $r$, where $0\le r\le 1/2$. The expected number of proliferative daughters is:Thus the proliferative population can maintain itself even when individual divisions have different outcomes. In a simplified critical branching process with division rate $\lambda$, the effective rates of clone-size increase and decrease are both $\lambda r$ per proliferative cell. Starting from one such cell:The product remains one: increasing mean size among surviving clones can accompany unchanged expected labelled cell number across all initial clones. These formulae illustrate survivor conditioning; actual tissue geometry, noncycling basal cells, finite compartments and local interactions can require a different quantitative model.

Work on mouse oesophageal epithelium combined label-retention assays with lineage tracing and found that a single proliferative population could account for maintenance. After wounding, its outcomes became biased toward producing proliferating daughters, then returned toward balance after repair. ^[ref] Changing the division rate and changing the probability of daughter fates are different responses. More divisions with unchanged balance can accelerate replacement without expanding the renewing pool; biased outcomes can expand that pool. Neither observation alone requires conversion of a terminally differentiated cell into a stem cell.

Evidence for heterogeneity also remained important. Marker-selected tracing and proliferation analysis in mouse epidermis supported distinct slow-cycling stem and committed progenitor compartments. ^[ref] Such results should not be dismissed simply because a single-progenitor model fits another dataset. Anatomical site, promoter expression, induction dose, chase duration and which cells are scored can change the sampled population. A driver that preferentially labels a slow-cycling subset and a broadly induced driver need not produce the same clone distribution. Models should be compared against joint measurements of clone survival, cell cycle kinetics and labelled differentiated output rather than one convenient summary statistic.

Live intravital imaging added information that destructive sampling cannot supply. Tracking the same cells shows which event precedes which: division, loss of basal contact, movement into a suprabasal layer, or neighbour expansion. In adult mouse epidermis, local differentiation was followed by neighbour expansion and compensatory cell cycle progression, supporting a mechanism in which cell loss locally stimulates self-renewal. ^[ref] Balanced stochastic clone statistics therefore need not mean that cells make independent random decisions insulated from their neighbours. A spatially coordinated system can generate population-level fate balance and apparent randomness at the level of individual retrospective clones.

Modern molecular methods refine, but do not replace, those functional tests. single-cell RNA sequencing identifies heterogeneous molecular states and pathway activity; spatial measurements locate them relative to basement membrane, follicles or wounds. A trajectory inferred from transcriptomes is not a directly observed lineage, and an intermediate expression profile can reflect a transient response rather than a cell reversing fate. Combining molecular profiling with permanent labels, repeated imaging and appropriately timed perturbations distinguishes state similarity, ancestry and causal requirement. cell cycle state and injury-associated inflammation also need to be separated from a genuinely distinct renewing population.

Direct evidence for cell fate plasticity requires more than changing proliferation within an existing progenitor class. Pre-injury labelling of GATA6-expressing differentiated sebaceous-duct cells showed that their descendants could move into wounded interfollicular epidermis, regain basal renewing properties and produce a broader range of epidermal descendants. Long-term tracing and live observations supported dedifferentiation under the wound conditions. ^[ref] The key comparison is the fate of the same pre-labelled population in undamaged and damaged tissue. It is not sufficient to find Gata6-lineage fluorescence in a cell that has just begun expressing the marker after injury.

Several controls make such a claim persuasive. Verify the initial labelled cell identities before damage; allow the inducer to clear; exclude rare pre-labelled stem cells or reporter leakage; and demonstrate sustained renewal rather than transient basal residence. Imaging a labelled cell's transition and showing its later functional output is stronger than a static double-positive image. Exclude cell fusion and selective expansion of an unrecognized initial subpopulation where relevant. Perturbing a proposed reprogramming regulator should preserve source-cell viability, since losing the source is not the same as preventing its identity change.

The general conclusion is a flexible hierarchy of evidence. Label retention measures division history, clonal tracing measures descendant output, live-cell imaging measures event order and local interactions, and molecular profiling measures state. Together they support dynamic population self-renewal, site-dependent heterogeneity and injury-induced epithelial plasticity, while leaving normal maintenance distinct from regenerative potential. Claims about one mouse skin region or oesophagus should be tested independently before being generalized to every squamous tissue or to humans.

Intestinal development constructs a patterned renewing organ; intestinal homeostasis continually replaces its cells while preserving that organization. Both depend on reciprocal signalling between endoderm-derived epithelium and mesenchyme, but they solve different problems. Development expands and regionalizes the tissue, establishes architecture and produces its first mature cell types. Adult tissue homeostasis balances cell production, cell differentiation, movement and loss within an already established architecture. The mammalian small intestine provides the main comparison; its villi and crypts should not be indiscriminately attributed to the colon or to all vertebrates.

Early intestinal development begins with a broadly proliferative epithelial tube whose regional identity is established in its embryonic context. Factors including CDX2 help impose intestinal identity, while local signals distinguish the future small intestine and colon. Growth is coordinated with the formation of smooth muscle, connective tissue, the enteric nervous system and vasculature. The emergence of intestinal villi transforms a relatively simple luminal surface into an absorptive one. In mouse, epithelial Hedgehog signalling promotes underlying mesenchymal clusters, and BMP signalling helps space those clusters. In explants, increased BMP activity suppresses clusters whereas BMP inhibition produces merged clusters and abnormal villus patterns. This supports a role in pattern generation, not simply in the terminal differentiation of enterocytes.^[ref]

The mechanics and signalling must be distinguished across species. In chick, sequential smooth muscle differentiation constrains growth, generating ridges, zigzags and villi through buckling. In mouse, patterned mesenchymal clusters arise before equivalent surface deformation, so the chick sequence is not a general account of mammalian villus initiation. The common principle is reciprocal communication between layers; the ordering of mechanical and chemical patterning differs. In development, therefore, an abnormal villus pattern could arise from defective mesenchymal organization, epithelial growth or mechanical coupling, even if the final epithelial cell differentiation markers are present.

As villi emerge, proliferative cells become concentrated in intervillus regions, and intestinal crypts develop chiefly around the perinatal and postnatal transition in mouse. The fetal proliferative epithelium is consequently not simply a miniature adult crypt. Paneth cells and other components of the mature niche also appear on their own developmental schedules. Demonstrating an adult stem-cell marker in an embryonic cell would not alone establish that the embryonic lineage hierarchy or niche requirements are identical to the adult ones.

In adult small-intestinal tissue homeostasis, cycling Lgr5 positive intestinal stem cells at crypt bases generate renewed stem cells and transit-amplifying cells. Descendants differentiate into absorptive enterocytes and secretory populations including goblet cells, enteroendocrine cells, tuft cells and Paneth cells. Most differentiated descendants move toward the villus tip and are shed, whereas Paneth cells occupy the crypt base. lineage tracing from the Lgr5 locus generated persistent contributions to all epithelial lineages, providing functional evidence for self-renewal and multipotency rather than relying on marker expression alone.^[ref]

The adult niche spatially restricts developmental pathways. High local Wnt signalling and R-spondin support crypt stemness and growth, while BMP signalling restrains crypt-like programmes outside their appropriate domain. Notch signalling favours absorptive over secretory lineage allocation partly by opposing ATOH1-dependent secretory specification. Thus a single pathway can control both population maintenance and cell composition: stimulating proliferation is not sufficient if the resulting cell differentiation balance is wrong. Stromal signals are essential in vivo, and Paneth cells provide additional local support in small intestine; the colon maintains stem cells without a small-intestinal Paneth-cell arrangement. Niche dependence cannot therefore be equated with dependence on one invariant supporting cell type.

The adult organ is dynamically stable rather than cellularly static. A stem-cell clone can expand while neighbouring stem-cell clones disappear through neutral drift, with the total compartment maintained.^[ref] At the organ level, sustained excess production generates expansion or neoplasia; excess loss causes barrier failure. Development deliberately changes total cell number, surface area and proportions over time, whereas adult maintenance constrains their long-term averages. Nevertheless, adult tissue homeostasis remains responsive to feeding, microbes, immune signals and injury, and is not a completely fixed endpoint.

Experimental models expose both continuity and differences. A single sorted Lgr5 positive cell can produce a self-renewing intestinal organoid containing organized differentiated progeny in a suitable matrix and supplied growth factors. This establishes epithelial self-organization under defined conditions, not niche independence in the absence of extracellular signals: the medium replaces important niche functions.^[ref] Embryonic explants retain the mesenchyme needed to study villus patterning, while adult intestinal organoids are especially useful for stem-cell maintenance and lineage allocation. Neither alone reproduces an intact organ's circulation, innervation, immune environment and longitudinal regionalization.

Finally, injury reveals an important bridge between development and maintenance. cell fate plasticity can restore missing stem cells, so the normal adult lineage flow is not an irreversible restriction of all descendants. Committed progenitor cells can recover stem-cell function under particular injury conditions, but this does not establish that all mature villus cells routinely do so. A decisive comparison uses stage-specific lineage tracing, matched marker analysis and timed pathway perturbation, measuring architecture and functional output as well as cell proliferation. Development and adult renewal reuse molecular machinery while differing in tissue geometry, developmental competence and the direction of net population change.

Epithelial cell fate plasticity is a context-dependent change in developmental potential or differentiated identity. It includes dedifferentiation toward a progenitor cell state, transdifferentiation between differentiated identities, and reversible intermediate states. It is distinct from selecting a pre-existing rare stem cell, and from ordinary progression down a lineage. epithelial-mesenchymal plasticity is one important form, but changing epithelial subtype without losing epithelial organization is also cell fate plasticity.

The strongest physiological rationale is that a tissue needs both stable specialization and reserve routes for replacement. During ordinary adult tissue homeostasis, a stem-cell hierarchy can efficiently supply predictable cell types. After injury removes a component of that hierarchy, local signals and newly available stem-cell niche space may permit a committed descendant to reacquire self-renewal. In mouse intestine, Alpi marked enterocyte-lineage progenitor cells normally generate short-lived absorptive descendants. After targeted ablation of Lgr5 positive intestinal stem cells, labelled progenitor cells can generate long-lived crypt-villus lineages with renewed stem-cell output. Comparing the same labelled population before and after ablation distinguishes injury-dependent cell fate plasticity from its normal fate. The experiment concerns progenitor cells in the enterocyte lineage; it should not be generalized to every terminally mature villus enterocyte.^[ref]

A complementary model is the mouse airway. Genetic depletion of basal stem cells, combined with prior lineage tracing of luminal secretory cells, revealed secretory-cell descendants that acquired basal-cell properties and sustained subsequent epithelial production. Experiments with isolated cells and cocultures further showed that contact with basal cells inhibits this conversion. cell fate plasticity is therefore regulated by the tissue environment, not simply an intrinsic capacity unmasked whenever a marker changes. Its interpretation requires controls for residual basal cells and for whether the secretory-lineage driver labelled basal cells before injury.^[ref]

Development provides additional contexts. Embryonic epithelia can undergo epithelial-to-mesenchymal transition during processes such as gastrulation, and mesenchymal-to-epithelial transition can subsequently assemble epithelial structures. These are regulated changes in adhesion, cell polarity, motility and gene expression, rather than a simple binary switch read from E-cadherin alone. In wound repair, transient relaxation of epithelial organization can facilitate migration while retaining intercellular contacts. A partially migratory repair state need not entail a complete mesenchymal conversion or a permanent change of lineage. Following wound closure, restoration of barrier function and polarized architecture is as important as the initial ability to move.

The most convincing experimental design labels a defined starting population irreversibly before the inducing event, allows the inducer to clear, then follows labelled descendants through the transition. Check immediate labelling specificity, include no-inducer and uninjured controls, quantify labelling efficiency and rule out ectopic driver activation after injury. Demonstrate the new state with multiple markers, morphology and function, and persistence after the inducing signal is removed. Serial epithelial production or a second injury challenge tests stable self-renewal; a transient appearance of a basal marker does not. Sparse labelling and continuous live-cell imaging help distinguish conversion from contamination, cell fusion or selective expansion of a rare initially unrecognized progenitor cell.

single-cell RNA sequencing can identify intermediate cell states and candidate regulators, but inferred trajectories are not lineage histories. Combine it with genetic barcodes, spatial localization and timed perturbation of candidate transcription factors or niche signals. Organoids offer defined media, prospective cell isolation and manipulation of matrix stiffness. A sorted population's ability to make a structure in culture establishes potential under those conditions; dissociation and a permissive medium may induce a capacity rarely used in vivo. Compare culture results with intact-tissue fate mapping before claiming a normal physiological contribution.

The evolutionary argument is a trade-off, rather than a claim that every plastic response is an adaptation. Conditional access to alternative cell fates could buffer environmental injury and permit repair without maintaining a separate reserve stem-cell pool for every possible lesion. Conserved signalling modules can also be redeployed in new developmental contexts. These advantages must be weighed against loss of specialized function, energetic costs and the danger of inappropriate persistent growth. Comparative experiments should ask whether homologous lineages undergo similar transitions under comparable injuries; shared expression of a few regulators is insufficient to prove that an ancestral cell fate plasticity programme has been conserved. At the tissue level, cell fate plasticity supplies alternative states on which selection can act, but it does not itself establish heritable evolutionary change.

Clinically, controlled cell fate plasticity may improve epithelial repair, provide transplantable cells and make patient-derived disease models. The same capacity can undermine treatment: a tumour may switch to a less drug-sensitive lineage or regenerate a stem-like population after therapy. In carcinoma, epithelial-mesenchymal plasticity can contribute to invasion and treatment resistance, but neither a single EMT marker nor its absence establishes the mechanism of metastasis. In a lineage-traced mouse lung-cancer model, the tested EMT programme was dispensable for lung metastasis while contributing to chemoresistance; the conclusion is specific to that model and reporter coverage.^[ref] The useful clinical aim is therefore a defined, reversible transition that restores function, with evidence that it does not leave a persistently proliferative or malignant population.

A progenitor cell is a precursor with relatively restricted differentiation potential and, generally, more limited self-renewal than a stem cell. Usage depends on the lineage and assay; an expression marker alone does not establish renewal capacity.

A stem cell can produce both renewed stem cells and differentiated descendants. Its developmental range depends on the type and setting; self-renewal does not imply unrestricted cell fate.